Today
-11.24%
5 Days
-15.63%
1 Month
-29.01%
6 Months
-12.32%
Year to Date
-23.39%
1 Year
-42.46%
• Axon announced a $1.0 billion public offering of convertible senior notes. • Higher hardware costs and margin pressures contributed to the stock sell-off. • Technical indicators showed a MACD sell signal and an oversold Williams %R.
• Axon reported strong second-quarter revenue and raised its full-year outlook. • Growth is driven by TASER devices, body cameras, and software. • Analysts issued bullish ratings with an average price target of $699.68.
• Quarterly earnings reveal margin compression due to integration costs and product mix shifts. • Management lowered full-year earnings guidance, triggering investor concern regarding future profitability. • Federal regulatory inquiries into algorithmic biases threaten long-term software revenue and contract renewals.


| Shareholders | Proportion |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 6.89% |
| Vanguard Capital Management, LLC | 6.26% |
| Vanguard Portfolio Management, LLC | 4.47% |
| State Street Investment Management (US) | 4.40% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 50.62% |
| Investment Advisor/Hedge Fund | 26.79% |
| Individual Investor | 4.30% |
| Hedge Fund | 2.87% |
Related Instruments